Форма представления | Тезисы и материалы конференций в зарубежных журналах и сборниках |
Год публикации | 2017 |
|
Киселева Анна Алексеевна, автор
|
|
Киселева Анна Алексеевна, автор
|
Библиографическое описание на языке оригинала |
The primary cilium is an antenna-like structure protruding from the cell
surface, which provides a platform for receptors for signaling systems including
PDGF-alpha, Hedgehog, Wnt, and others that influence cell differentiation and
proliferation decisions. Under normal physiological growth conditions, the cilium
forms after mitosis and in quiescent cells, extending from a basal body
centered at a centriole, with timed resorption in G0 or early G1. Cancer cells
have altered ciliary dynamics, with some (medulloblastomas and basal cell carcinomas)
often dependent on cilia, and other tumor types downregulating them.
In prior work, we defıned Aurora-A, an oncogenic kinase typically thought of as
a mitotic regulator, as transiently activated at the basal body, and absolutely
required for resorption of cilia at the G0/G1 boundary, and we showed the
targeted Aurora-A inhibitor entirely blocked ciliary resorption. In subsequent
work, we found that a second drug, the EGFR inhibitor erlotinib, al |
Ключевые слова |
primary cilium, ALisertib, Sunitinib |
Место издания |
Washington DC |
Издательство |
AACR |
URL |
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=105&DetailItemID=539&utm_source=social&utm_medium=twitter&utm_content=am17&utm_campaign=annual-meeting#.WU-7Amg19PY |
Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку |
https://repository.kpfu.ru/?p_id=160420 |
Полная запись метаданных |
Поле DC |
Значение |
Язык |
dc.contributor.author |
Киселева Анна Алексеевна |
ru_RU |
dc.contributor.author |
Киселева Анна Алексеевна |
ru_RU |
dc.date.accessioned |
2017-01-01T00:00:00Z |
ru_RU |
dc.date.available |
2017-01-01T00:00:00Z |
ru_RU |
dc.date.issued |
2017 |
ru_RU |
dc.identifier.citation |
The primary cilium is an antenna-like structure protruding from the cell
surface, which provides a platform for receptors for signaling systems including
PDGF-alpha, Hedgehog, Wnt, and others that influence cell differentiation and
proliferation decisions. Under normal physiological growth conditions, the cilium
forms after mitosis and in quiescent cells, extending from a basal body
centered at a centriole, with timed resorption in G0 or early G1. Cancer cells
have altered ciliary dynamics, with some (medulloblastomas and basal cell carcinomas)
often dependent on cilia, and other tumor types downregulating them.
In prior work, we defıned Aurora-A, an oncogenic kinase typically thought of as
a mitotic regulator, as transiently activated at the basal body, and absolutely
required for resorption of cilia at the G0/G1 boundary, and we showed the
targeted Aurora-A inhibitor entirely blocked ciliary resorption. In subsequent
work, we found that a second drug, the EGFR inhibitor erlotinib, al |
ru_RU |
dc.identifier.uri |
https://repository.kpfu.ru/?p_id=160420 |
ru_RU |
dc.language.iso |
ru |
ru_RU |
dc.publisher |
AACR |
ru_RU |
dc.subject |
primary cilium |
ru_RU |
dc.subject |
ALisertib |
ru_RU |
dc.subject |
Sunitinib |
ru_RU |
dc.title |
Unexpected activity of multiple targeted cancer drugs in regulating ciliary dynamics |
ru_RU |
dc.type |
Тезисы и материалы конференций в зарубежных журналах и сборниках |
ru_RU |
|